VVOS 最新季度财报
公布日期8/14/2026
实际每股收益(美元)-0.31
实际营收(美元)5.15M
本页面提供详细的 Vivos Therapeutics Inc 财报数据,包括最新财报、下一次财报发布日期、历史数据及 Vivos Therapeutics Inc 财报电话会相关新闻。
| 发布日期 | 报告期末 | 每股收益/预测值 | 营收/预测值 | 每股收益超预期幅度 % | 营收超预期幅度 % |
|---|---|---|---|---|---|
| 8/14/2026 | 06/2026 | -0.31/-0.39 | 5.15M/5.37M | 19.83% | -3.98% |
| 5/22/2026 | 03/2026 | -0.52/-0.45 | 5.14M/4.22M | -15.80% | 21.68% |
| 4/15/2026 | 12/2025 | -0.55/-0.48 | 3.82M/6.45M | -14.81% | -40.69% |
| 11/19/2025 | 09/2025 | -0.49/-0.51 | 6.78M/4.81M | 3.42% | 40.96% |
| 8/19/2025 | 06/2025 | -0.55/-0.39 | 3.82M/3.78M | -43.29% | 0.99% |
| 5/15/2025 | 03/2025 | -0.45/-0.40 | 3.02M/3.67M | -12.39% | -17.74% |
| 3/31/2025 | 12/2024 | -0.39/-0.40 | 3.70M/3.89M | 1.05% | -4.83% |
| 11/14/2024 | 09/2024 | -0.40/-0.61 | 3.86M/4.06M | 35.17% | -4.95% |
Vivos Therapeutics (VVOS) 2026财年第二季度业绩电话会:营收增长35%,流动性风险仍存